RE: US News Fresh Today12 May 2020 19:27
In addition to the FDA’s work to expedite preventative and therapeutic options, the agency is engaged in a public-private partnership with the National Institutes of Health and others to speed the development of COVID-19 vaccine and treatment options. The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership, which also includes other U.S. and European government partners and more than a dozen biopharmaceutical companies, will develop a collaborative framework for prioritizing vaccine and drug candidates, streamlining clinical trials, coordinating regulatory processes and/or leveraging assets among all partners to rapidly respond to COVID-19 and future pandemics.
So..... Could it be possible that SNG are registering on the NIH trial register in the US to enable them to be fast tracked for approval by the FDA upon successful trial results, like Remdisivir? Otherwise why bother registering there. Possibly a quicker way to market than in UK or Europe. Nice to hear peoples thoughts on that.? DYOR.